关于COVID-19对糖尿病患者的长期影响的批判性审查
Sumel Ashique1, Neeraj Mishra2, Ashish Garg3
1Department of Pharmaceutical Sciences, Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, India.
The American journal of medicine
|March 14, 2024
概括
糖尿病患者面临COVID-19的风险增加,包括较高的死亡率. 研究探讨了SARS-CoV-2如何影响糖尿病患者以及潜在的治疗策略,以获得更好的结果.
科学领域:
- 内分泌学 在内分泌学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 冠状病毒疾病2019 (COVID-19) 是一个全球性的健康危机.
- 患有糖尿病的人面临更高的COVID-19严重后果的风险.
- 本综述总结了SARS-CoV-2对糖尿病患者的长期影响.
研究的目的:
- 提供COVID-19对糖尿病患者的长期影响的实用概述.
- 检查SARS-CoV-2的影响,死亡率,机制和糖尿病并发症.
- 探索维生素D和在糖尿病中控制COVID-19中的作用.
主要方法:
- 在PubMed,科学网和科学直播上进行文献搜索.
- 搜索仅限于英语出版物,直到2023年4月.
主要成果:
- 对于糖尿病患者来说,COVID-19带来了重大挑战,可能会延长康复的时间.
- 老年人和患有糖尿病的人更容易感染COVID-19.
- 高血糖水平可能促进SARS-CoV-2复制;抗糖尿病药物显示治疗潜力.
结论:
- 糖尿病显著增加了COVID-19患者的发病率和死亡率风险.
- 全球努力的重点是开发干预措施,以减轻糖尿病对COVID-19的影响.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
533
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
533
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
927
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
927
Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
Diabetes: Management and Pharmacotherapy
281
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
281


